Mammalian circadian clocks provide a temporal framework to synchronize biological functions. To obtain robust rhythms with a periodicity of about a day, these clocks use molecular oscillators consisting of two interlocked feedback loops. The core loop generates rhythms by transcriptional repression via the Period (PER) and Cryptochrome (CRY) proteins, whereas the stabilizing loop establishes roughly antiphasic rhythms via nuclear receptors. Nuclear receptors also govern many pathways that affect metabolism and physiology. Here we show that the core loop component PER2 can coordinate circadian output with the circadian oscillator. PER2 interacts with nuclear receptors including PPARa and REV-ERBa and serves as a coregulator of nuclear receptor-mediated transcription. Consequently, PER2 is rhythmically bound at the promoters of nuclear receptor target genes in vivo. In this way, the circadian oscillator can modulate the expression of nuclear receptor target genes like Bmal1, Hnf1a, and Glucose-6-phosphatase. The concept that PER2 may propagate clock information to metabolic pathways via nuclear receptors adds an important facet to the clock-dependent regulation of biological networks. Many changes in physiology and behavior occur rhythmically with a period length of ;24 h, even in the absence of external timing cues. These circadian oscillations are generated by autonomous clock mechanisms that can be synchronized to environmental cues such as the daynight cycle. In mammals, circadian oscillations can be observed in most cells and tissues, where they play a role in the temporal organization of biochemical and physiological functions. Due to the cell-autonomous character of the circadian clock, a central coordinator is necessary to establish a stable phase relationship between the different tissue clocks. The main coordinator of all body clocks resides in the suprachiasmatic nucleus (SCN), a structure in the ventral part of the hypothalamus. This brain region perceives light information from the environment and subsequently synchronizes all peripheral clocks to generate coherent systemic rhythms for the entire organism (Liu et al. 2007 ).
Many changes in physiology and behavior occur rhythmically with a period length of ;24 h, even in the absence of external timing cues. These circadian oscillations are generated by autonomous clock mechanisms that can be synchronized to environmental cues such as the daynight cycle. In mammals, circadian oscillations can be observed in most cells and tissues, where they play a role in the temporal organization of biochemical and physiological functions. Due to the cell-autonomous character of the circadian clock, a central coordinator is necessary to establish a stable phase relationship between the different tissue clocks. The main coordinator of all body clocks resides in the suprachiasmatic nucleus (SCN), a structure in the ventral part of the hypothalamus. This brain region perceives light information from the environment and subsequently synchronizes all peripheral clocks to generate coherent systemic rhythms for the entire organism (Liu et al. 2007 ).
The mammalian circadian oscillator is based on a pair of transcriptional activators-BMAL1/MOP3 (Hogenesch et al. 1998; Bunger et al. 2000) and CLOCK (or NPAS2 in the brain) (King et al. 1997; Reick et al. 2001; DeBruyne et al. 2007a,b) -and at least two classes of transcriptional repressors that maintain two distinct regulatory loops. In the stabilizing loop, the nuclear receptor REV-ERBa accumulates rhythmically to repress the expression of various circadian genes, including Bmal1 and Clock (Preitner et al. 2002; Ueda et al. 2002) . Originally supposed to be a transcriptional activator (Harding and Lazar 1993) , REVERBa was later identified as a genuine transcriptional repressor that interacts with the corepressor N-CoR1 and the histone deacetylase HDAC3 to maintain a repressive state (Downes et al. 1996; Yin and Lazar 2005) . The repressive action of REV-ERBa is periodically counterbalanced by the nuclear receptor RORa, and in the liver by PPARa, to yield rhythmic gene expression (Sato et al. 2004; Canaple et al. 2006) .
In the core loop, circadian regulation of target genes is mediated via so-called E-box motifs, which are specific binding sites for BMAL1 and CLOCK. Complexes of PERIOD (PER) and CRYPTOCHROME (CRY) proteins perform repression of BMAL1-and CLOCK-mediated transcription (Gekakis et al. 1998; Griffin et al. 1999; Kume et al. 1999) . Upon reaching a certain threshold concentration, the PER proteins together with the CRY proteins repress their own transcription and that of other circadian genes, including the Rev-Erba gene. Two mammalian homologs of the Drosophila per gene important for mammalian circadian rhythms have been identified Shearman et al. 1997; Sun et al. 1997; Tei et al. 1997) . Manipulation of Per gene expression and activity in the mouse demonstrated a role for these genes in the circadian oscillator (Zheng et al. 1999 (Zheng et al. , 2001 Bae et al. 2001; Cermakian et al. 2001) . In analogy to the Drosophila feedback loop of circadian clock regulation (Hardin et al. 1990 ), the Per1 and Per2 genes were postulated to be negative regulators of the feedback loop in mammals without mechanistic distinction. However, there is evidence that PER1 and PER2 play nonredundant roles in the circadian clock; in particular, PER2 might act as a positive regulator (Zheng et al. 1999 (Zheng et al. , 2001 Shearman et al. 2000) .
The output from the circadian oscillator is mediated either by genes that are hardwired directly to the transcriptional network (Jin et al. 1999; Ripperger et al. 2000) , or by rhythmically expressed transcriptional regulators as intermediaries (Ueda et al. 2005) . Of recent interest is the family of nuclear receptors. More than half of the 49 mouse nuclear receptors display rhythmic mRNA accumulation patterns in many different phases, allowing for the rhythmic control of energy, glucose, and lipid metabolism (Yang et al. 2006 ). The nuclear receptors REV-ERBa, RORa, and PPARa are implicated in the clock mechanism of the stabilizing loop (Preitner et al. 2002; Sato et al. 2004; Canaple et al. 2006; Liu et al. 2008 ). Other nuclear receptors have known functions for the rhythmic control of tissue-specific output processes (Yang et al. 2006) . Coupling the expression of nuclear receptors directly to the transcriptional network would facilitate the temporal organization of the output processes under regular circumstances, but may be circuitous and inflexible in situations necessitating a rapid adaptation of the underlying transcriptional network to changes in the environment. Therefore, a mechanism modulating circadian nuclear receptor activity at the protein rather than the transcriptional level can be envisaged.
Exploring the differences between PER1 and PER2, we found that PER2 rather than PER1 acts as a coregulator of various nuclear receptors. This may explain many of the functional differences between the two PER proteins. In particular, the physical interaction of PER2 with PPARa and REV-ERBa allows for a modulation of Bmal1 gene regulation and a precise coupling of the core and the stabilizing loop. Additionally, PER2 and nuclear receptors affect rhythmic transcription of output genes like Hnf1a and Glucose-6-phosphatase involved in glucose homeostasis. Our results suggest that the physical interaction of PER2 with different nuclear receptors is a rapid means to modulate rhythmic gene expression, allowing the finetuning and optimization of cellular responses to environmental signals.
Results

Nuclear receptors form complexes with PER2
The PER proteins have the capability to interact with multiple proteins, but do not necessarily have the same binding partners. In addition to the known interaction partners, two classes of motifs have been described in the PER proteins (Albrecht et al. 2007 ) that resemble interaction motifs of nuclear receptors with their coregulators: the CoRNR and LXXLL motifs (Heery et al. 1997; Hu and Lazar 1999) . The potential CoRNR motifs of both PER proteins are quite conserved; however, the sequences of the potential LXXLL motifs differ (Fig. 1A) , presumably mediating different protein-protein interactions.
In accordance with the assumption that PER proteins could interact physically with nuclear receptors, PER2 coimmunoprecipitated with the upstream regulator of the Bmal1 gene, PPARa, from mouse liver nuclear extracts (Fig. 1B) . This interaction was more pronounced at ZT20 (Zeitgeber time 20; ZT0 is lights on and ZT12 lights off), the time of high Bmal1 expression (see below), suggesting a role of this complex for the activation of the Bmal1 gene. In contrast, PER1 protein did not coimmunoprecipitate significantly with PPARa (Fig. 1B) , although the known interaction with BMAL1 (Lee et al. 2001 ) was observed (Fig. 1C) . In order to investigate further the physical interaction between PER2 and nuclear receptors, we supplemented mouse NIH 3T3 fibroblasts with an expression vector for V5-tagged PER2 and expression vectors for HA-tagged nuclear receptors. We selected representatives of various nuclear receptor subfamilies expressed in liver tissue based on either of two criteria: known influence on the circadian oscillator, or rhythmic expression in the phase of PER2 accumulation (Yang et al. 2006) . We found that V5-tagged PER2 coimmunoprecipitated with REV-ERBa, PPARa, HNF4a, and TRa, and, to a lesser extent, with NURR1 and RORa (Fig.  1D) . No reproducible interaction was observed for the nuclear receptors ERa and RXRa. The interaction of the same nuclear receptors with V5-tagged PER1 was much weaker (Supplemental Fig. 1A,B) , although V5-tagged PER1 coimmunoprecipitated equally as well as V5-tagged PER2 with HA-CRY1 (Supplemental Fig. 1C) .
The in vitro experiments indicate interaction of PER2 with REV-ERBa, the transcriptional repressor of Bmal1. Similarly, PER2 also coimmunoprecipitated REV-ERBa in mouse liver nuclear extracts (Fig. 1E) . The observed coimmunoprecipitation was comparable with the one observed with BMAL1. However, the precipitates were observed roughly at the opposite time (ZT8 and ZT12) as compared with precipitates containing PPARa (ZT20) (Fig. 1B,E; Supplemental Fig. 1D ). In conclusion, both PER proteins interact with components of the core loop, whereas PER2 has the capacity to coimmunoprecipitate with some of our selected nuclear receptors.
PER2 interacts with PPARa or REV-ERBa via its LXXLL sequence motifs
The differential interaction potential of the PER1 and PER2 proteins with nuclear receptors may be rooted in the sequence of the LXXLL-like motifs found in these proteins (Fig. 1A) . Replacement of the leucine residues by alanines in the N-terminal but not in the C-terminal motif of PER2 abolished interaction with PPARa (mLCCLL and mLLNLL) ( Fig. 2A; Supplemental Fig. 2D) to a comparable extent as the mutation of both LXXLL sequences (mLXXLL). This was not due to a general conformational change of the PER2 mutant proteins, because they could still bind to CRY1 (Supplemental Fig. 2A) . Similarly, the interaction of PER2 with REV-ERBa relied on the N-terminal motif but not the C-terminal motif, as demonstrated by mutation and deletion analysis ( Fig. 2B ; Supplemental Fig. 2B,D) . In conclusion, it appears that the N-terminal motif is involved mainly in the interaction between PER2 and nuclear receptors.
The specificity of interaction between LXXLL motifs and nuclear receptors is mediated partially by a conserved lysine residue in helix 3 of the ligand-binding domain (LBD) of nuclear receptors (Savkur and Burris 2004) . Therefore, we replaced the corresponding lysine residue in helix 3 of REV-ERBa by an alanine. This mutation (K456A) reduced the potential of REV-ERBa to bind to PER2 by ;60%, and deletion of the entire LBD by ;90% ( Fig. 2C; Supplemental Fig. 2C,D) . A similar point mutation in PPARa (K292A), however, had less impact on the interaction with PER2, as did the deletion of its helix 12, which represents a second anchor point for LXXLL motifs of nuclear receptors ( Fig. 2C; Supplemental Fig. 2D ). While REV-ERBa has the potential to directly bind PER2, our data suggest that PPARa may interact only indirectly with PER2, probably as a heterodimer with other nuclear receptors.
To assign a function to the LXXLL-like motifs, we investigated the impact of the PER proteins on the expression of Rev-Erba or Bmal1 as genes regulated by the core or stabilizing loop, respectively. NIH 3T3 cells were transfected with adequate luciferase reporter genes, and the rhythmic bioluminescence of cultures was monitored continuously for multiple days. Cotransfection of either Per1 or Per2 reduced the activity of the Rev-Erba luc reporter in a similar and dose-dependent fashion ( Fig. 2D ; Supplemental Fig. 2E,F) . In contrast, the same amounts of either expression vector had divergent effects on the Bmal1 luc reporter (Fig. 2E) . Cotransfection of increasing amounts of Per1 reduced the amplitude of Bmal1 luc expression, while increasing amounts of Per2 provoked a dose-dependent increase with dampened amplitude (Supplemental Fig. 2E,F) . Surprisingly, the same mutations that weakened the interaction of PER2 with nuclear receptors converted the Bmal1 regulatory potential of PER2 into that of PER1 ( Fig. 2E; Supplemental Fig. 2E ). This may indicate that the LXXLL sequences in PER2 are important for the regulation of the Bmal1 gene. PER2 binds in a REV-ERBa-dependent fashion to the Bmal1 promoter in vivo If the complex of PER2 with nuclear receptors mediates transcriptional regulation, then the presence of both should overlap at the regulatory regions of their target genes. We used chromatin immunoprecipitation (ChIP) to investigate regulatory regions of circadian target genes in vivo. Both PER1 and PER2 were detected at the Rev-Erba gene in a phase coinciding with the repression of this gene, and this binding was independent of REV-ERBa ( Fig.  3A ; Supplemental Fig. 3A) . Surprisingly, we found that PER2 bound to the promoter region (+50) of the Bmal1 gene in a phase coinciding with the repression of this gene ( Fig. 3B; Supplemental Fig. 3A ). Binding of PER2 overlapped with binding of REV-ERBa to the same region. The detection of PER2 was clearly dependent on the binding of the REV-ERBa protein, because in Rev-Erba-deficient mice, neither PER2 nor REV-ERBa was bound at the Bmal1 promoter. Binding of PER1 was not observed at this promoter. Similarly, binding of PER2 but not PER1 was observed at the upstream regulatory region (À1600) of the Bmal1 gene containing binding sites for PPARa ( Fig. 3C ; Canaple et al. 2006 ), or at the promoter region of the HNF4a-controlled Hnf1a gene ( Fig. 3D ; Tian and Schibler 1991) . In these cases, PER2 binding overlapped with PPARa or HNF4a and correlated with the activation or repression of these target genes, respectively ( Fig.  3C,D; Supplemental Fig. 3A) . As a control, binding of PER2 was not observed at any of these promoters in Per2
Brdm1 mice (Supplemental Fig. 3B ). Taken together, we identified three different ways that PER2 can bind to promoters of circadian genes: (1) REVERBa-dependent binding as observed on the Bmal1 promoter; (2) PPARa or HNF4a correlated binding, as seen for the upstream region of Bmal1 or the Hnf1a promoter, respectively; and (3) BMAL1 correlated binding (Supplemental Fig. 3C ), as evidenced on the Rev-Erba promoter, a property that is shared by PER1. These results from ChIP experiments strongly favor our hypothesis that PER2 modulates gene expression not only via the known interaction with BMAL1, but also via interactions with nuclear receptors. Hence, due to these interactions, PER2 has much more regulatory potential than previously thought. 
PER2 and nuclear receptors modulate the expression of the Bmal1 gene in the liver
To assign a biological function to the interaction of PER2 with REV-ERBa, we generated mice deficient for both genes and consequently lacking Per2 and Rev-Erba mRNA expression (Supplemental Fig. 4A-C) . Strikingly, in the liver of Rev-Erba À/À /Per2 mutant animals, Bmal1 mRNA accumulation was no longer rhythmic ( Fig. 4A) . Instead, this gene was expressed at a constant level corresponding to the maximum of Bmal1 expression found in Per2
Brdm1 mice on the one hand, and representing roughly the median of the rhythmic Bmal1 accumulation in Rev-Erba À/À mice on the other hand. These results suggest that, for the activation of the Bmal1 gene, the interaction of PER2 with REV-ERBa in vivo is not essential, and that at least one other interaction partner of PER2 exists that can synergistically regulate expression of the Bmal1 gene in the liver. A candidate could be PPARa. Our results indicate that this nuclear receptor can be immunoprecipitated with PER2 in liver nuclear extracts (Fig. 1B) . In addition, PPARa and PER2 are found at the same time at the upstream regulatory region of the Bmal1 gene (Fig. 3C ). To monitor a potential synergistic effect between PPARa and PER2, we referred again to our in vitro fibroblast system. The original Bmal1 luciferase reporter construct (Bmal1 luc) does not contain PPARa regulatory sites. Therefore, we extended this construct by 822 base pairs (bp) of upstream promoter sequence to include a PPARa regulatory site (Canaple et al. 2006 ). This construct (Bmal1 ext. luc) displayed a threefold to fivefold higher magnitude of expression compared with the shorter construct (data not shown), indicating that, in these additional 822 bp, important elements for Bmal1 expression in fibroblasts are present. Surprisingly, PPARa, together with its heterodimerization partner, RXRa, had only a slight enhancing effect on Bmal1 ext. luc reporter expression (Fig. 4B ).
However, cotransfection of PER2 yielded a dose-dependent overall increase in reporter gene activity, which was dependent on functional LXXLL sequences in PER2. In concert with PPARa (and RXRa), PER2 appears to function as a coactivator under our in vitro conditions. In conclusion, the regulation of the Bmal1 gene in the liver is modulated by two circadian mechanisms: rhythmic repression by REV-ERBa (with a slight contribution of PER2), and rhythmic activation by other nuclear receptors that use PER2 as a coactivator, such as PPARa.
Although the mRNA accumulation of Bmal1 was found to be no longer rhythmic in Rev-Erba À/À mice (dashed lines) was prepared at 4-h intervals from mice held in a 12-h light/12-h dark cycle (LD 12:12) . The binding of the indicated proteins to their regulatory region was analyzed by ChIP. Specific TaqMan probes were used to detect the Rev-Erba promoter region (A), the Bmal1 promoter region (+50, B), the Bmal1 upstream regulatory region (À1600, C), and the Hnf1a promoter region (D). Plotted are the mean values 6 SEM from three independent experiments; ZT0 is double-plotted. (*) The regulatory region preceding the Rev-Erba knockout allele. modulation of Bmal1 expression. We hypothesize that the tissue-specific effects on Bmal1 expression might be the result of the differential presence of PPARa in liver and SCN tissue. This idea is in agreement with the observation that PPARa expression is not detected in the SCN (see Allen Brain Atlas, http://www.brain-map.org). It is tempting to speculate that other nuclear receptors might replace PPARa function in the SCN. Taken together, tissue-specific regulation of clock gene expression may be due to the presence of particular nuclear receptors in a given tissue (Yang et al. 2006 ) interacting with PER2.
An output of the central pacemaker in the SCN is circadian locomotor activity under free-running conditions (e.g., constant darkness). This can be measured using a wheel-running setup to monitor activity (Fig.  5D ). Under these conditions, Rev-Erba À/À /Per2 mutant mice had a significantly shorter period length compared with wild-type, Rev-Erba À/À , and Per2 Brdm1 mice (Supplemental Fig. 5A-C) . In contrast to Per2
Brdm1 animals, 50% of double-mutant animals showed a stable circadian rhythm throughout at least 5 wk in constant darkness (Fig. 5D, middle panel) . The other 50% of the animals lost their circadian rhythmicity when held in constant darkness for an average of 21 d (Fig. 5D, right panel) . The ratio of rhythmic to arrhythmic animals was more or less constant, independent of gender or pedigree (data not shown). Interestingly, individual double-mutant mice could switch from arrhythmic to rhythmic behavior under prolonged constant conditions (Supplemental Fig.  5D ). These behavioral changes could not be traced back to accidental exposure of the animals to an external Zeitgeber. Altogether, our data revealed two characteristics of the circadian behavior in Rev-Erba À/À /Per2 mutant mice: First, double mutants have a very short freerunning period length; and second, the behavioral phenotype observed in Per2
Brdm1 mice is partially rescued, possibly due to an increase of Bmal1 expression.
Potential impact of PER2 and REV-ERBa on the glucose metabolism of the liver Nuclear receptors are involved in the rhythmic regulation of various metabolic pathways in the liver (Yang et al. 2006) . We analyzed the function of PER2 on the expression of genes that have been described previously as targets of REV-ERBa and are involved in glucose metabolism (Yin et al. 2007; Le Martelot et al. 2009 ). The mRNA accumulation of the gluconeogenic enzyme Phosphoenolpyruvate-carboxykinase1 (Pepck1) was circadian in the different genetic backgrounds (Fig. 6A ) in a similar phase as the Per1, Dbp, and Rev-Erbb genes ( Fig. 4C ; Supplemental Fig. 4D ,E), suggesting that PER2 acts via BMAL1 and CLOCK on this gene and that PER1 can 
Brdm1 (blue), and Rev-Erba À/À /Per2 mutant (red) animals; ZT0 is double-plotted.
compensate for the loss of PER2 function. In agreement with Le Martelot et al. (2009) , we find only a minor effect of the deletion of Rev-Erba on the regulation of the Pepck1 gene. However, the function of REV-ERBa could be compensated by REV-ERBb, since the Rev-Erbb gene is still rhythmically expressed in all of our genetic backgrounds (Supplemental Fig. 4E) .
In contrast to the rhythmic expression of the Pepck1 gene, the expression of a key enzyme of glucose metabolism, Glucose-6-phosphatase (G6Pase), was affected in Rev-Erba À/À -deficient mice and Per2 Brdm1 animals. However, this expression was constant in Rev-Erba À/À /Per2 mutant mice (Fig. 6B) , similar to the Bmal1 gene (Fig. 4A) . At the promoter of the G6Pase gene, we could detect rhythmic PER2 binding in vivo (Supplemental Fig. 6A ). This binding correlated with the transcriptional repression of this gene (Fig. 6B) . However, based on the different mRNA accumulation patterns of Bmal1 and G6Pase, and the different kinetics of PER2 binding to the regulatory regions in vivo in the single-mutant mice, we conclude that PER2 mediates this transcriptional repression not via REV-ERBa, but another, yet to be specified, nuclear receptor.
It is tempting to speculate that PER2 couples different metabolic pathways (i.e., the BMAL1/CLOCK and nuclear receptor-driven ones). Without this coupling, there may occur a desynchronization of metabolic pathways in otherwise circadian liver cells, as observed, e.g., for the enzymatic activities of PEPCK and G6Pase in the doublemutant mice (Fig. 6C,D) . This may have direct or indirect consequences on glucose metabolism in the liver. To address this point, we characterized hepatic functions of Rev-Erba À/À /Per2 mutant mice. In spite of normal patterns of food consumption (Supplemental Fig. 6B ), steadystate levels of glycogen in the liver were blunted in RevErba À/À /Per2 mutant mice (Fig. 6E,F) . However, the molecular mechanism leading to this phenotype is complex. In addition to the temporal shift of Pepck1 expression and the constant expression of G6Pase, the mRNA accumulation patterns of glucokinase, glycogen synthase, glycogen phosphorylase, phosphofructokinase, fructose-1, 6-bisphosphatase, and the glucose transporter Glut2 were deregulated in Rev-Erba À/À /Per2 mutant mice (data not shown). Since the glycogen store can be used to stabilize the blood glucose concentration, it is not surprising that we observed a slight hypoglycemic state at ZT12 in these mice (Supplemental Fig. 6C ) and also in Per2
Brdm1 mice, which also display a glycogen accumulation phenotype (Fig. 6E) . Taken together, our data point toward a function of PER2 to coordinate nuclear receptor-regulated pathways with the circadian oscillator.
Discussion
Functional differences of PER1 and PER2
Comparing PER1 and PER2 proteins, we identified a motif in PER2 that extends its regulatory capacity, most probably by interaction with nuclear receptors. Between the two PAS domains, which mediate the interaction with BMAL1 and CLOCK, a potential LXXLL motif was identified. Substitution of its leucines by alanines or its deletion (data not shown) converted the Bmal1 regulatory potential of PER2 into that of PER1 ( Fig. 2E ; Supplemental Fig. 2E ). However, replacing the LXXLL motifs of PER1 with the ones of PER2 did not convert PER1 into an activator of the Bmal1 gene (data not shown). Consequently, there may be further amino acids involved that mediate or prevent interactions necessary for the activation of the Bmal1 gene. Recently, a partial tertiary structure of PER2 was resolved containing both PAS domains (Hennig et al. 2009 ). In this structure, the LCCLL motif is embedded in a flexible linker region emerging from the PAS-A domain. One can speculate that the region between the two PAS domains could trigger interaction of PER2 with either BMAL1 and CLOCK, or nuclear receptors. The comparable region of PER1 may not be flexible enough or may not be accessible to allow both kinds of interactions. As a result, PER2 interacts much more strongly than PER1 with our selection of nuclear receptors (Supplemental Fig. 1A,B) .
Even though LXXLL-like motifs are important for interaction of nuclear receptors with PER2, this kind of interaction may not follow classical coactivator/nuclear receptor interactions. REV-ERBa does not possess a C-terminal helix 12 necessary to stabilize interaction with a typical LXXLL motif (Savkur and Burris 2004) . In spite of this, we could identify Lys 456 as important ( Fig.  2C; Supplemental Fig. 2D ). In many nuclear receptors, a comparable lysine directly interacts with the two neighboring leucine residues of the LXXLL motif or similar amino acids of the coregulator N-CoR1 (Hu and Lazar 1999; Savkur and Burris 2004) . We can envision a similar function of this particular residue for the interaction of REV-ERBa with PER2. Other mutations of REV-ERBae.g., preventing the binding of the prosthetic heme group by a deletion of the last 28 amino acids (DC) (Supplemental Fig. 2C ) or by a replacement of His 602 with phenylalanine (Raghuram et al. 2007) , or preventing the binding of the corepressor N-CoR1 (six amino acids that directly contact N-CoR1 replaced by alanines) (Woo et al. 2007 )-did not abolish the interaction with PER2 (data not shown).
PER2 may function as a modulator of Bmal1 gene expression when complemented with nuclear receptors. Cotransfection of PER2 with PPARa and RXRa yielded a dose-dependent increase of Bmal1 activity (Fig. 4B) , while cotransfection of REV-ERBa reduced the activation potential of PER2 (Supplemental Fig. 7, troughs) . Since REV-ERBa recruits also the corepressor N-CoR1 for its repressive function (Harding and Lazar 1995) on the Bmal1 promoter (Yin and Lazar 2005) , one could envisage a competition between PER2 and N-CoR1 for the same binding pocket in REV-ERBa. This competition might be influenced by heme, because the activity of the REVERBa/N-CoR1 complex seems to be modulated by the presence of this ligand (Yin et al. 2007) . In contrast, the interaction of REV-ERBa and PER2 is resistant to the depletion or augmentation of the endogenous heme pool in NIH 3T3 cells (Supplemental Fig. S8 ). At the moment, however, we cannot rule out that in vivo binding of heme might have a regulatory influence on the strength of this interaction, allowing integration of the metabolic state via the interaction of PER2 with REV-ERBa.
Dynamics of PER2 binding to regulatory regions of circadian clock and clock-controlled genes
Our data suggest that PER2 can bind to many nuclear receptor target genes in vivo. Surprisingly, this binding correlated with the binding of several nuclear receptors and occurred in many different phases of the circadian cycle. It is tempting to speculate that post-translational modifications of PER2 or the nuclear receptors confer specificity to such interactions. We found two nuclear receptors in the regulatory regions of the Bmal1 gene in the liver: REV-ERBa and PPARa (Fig. 3) . At the promoter region, the rhythmic binding of REV-ERBa is in line with the hypothesis that it is a negative regulator of the Bmal1 gene ( Fig. 3B ; Preitner et al. 2002; Liu et al. 2008) . At the upstream regulatory element, we found rhythmic binding of PPARa in the phase of transcriptional activation ( Fig.  3C ; Canaple et al. 2006 ). However, we found evidence that PER2 contributes to the circadian regulation of this gene as well. PER2 bound to two distinct regions of the Bmal1 gene in two different phases (Fig. 3B,C) . At the promoter, PER2 interacts with REV-ERBa in a phase that correlates with transcriptional repression and contributes ;10% to the overall repression (Fig. 4A, trough) . In contrast, at the upstream regulatory region, the binding of PER2 contributes ;25% to the overall transcriptional activity (Fig. 4A,  peak) . Most probably, this effect is mediated via PPARa. Our results show for the first time that PER2 binds at the Bmal1 regulatory region, and thereby has an influence on the magnitude and amplitude of Bmal1 expression.
From our genetic analysis, we conclude that PER2 may affect the regulation of the Hnf1a gene in the liver (Supplemental Fig. 3A) . We speculate that this effect might be mediated via HNF4a, because PER2 can be immunoprecipitated with this nuclear receptor (Fig. 1D ) and both proteins are present at the same time at the Hnf1a promoter (Fig. 3D ). HNF1a and HNF4a are both transcription factors at the crossroads of glucose homeostasis. Mutations in those genes lead to maturity-onset diabetes in the young (MODY) (Yamagata et al. 1996a,b) caused by an insulin secretion defect. Hence, Per2
Brdm1 mutant animals may show alterations in glucose homeostasis, as observed previously for Bmal1 and Clock mutant mice Lamia et al. 2008) .
Binding of PER2 but also PER1 to the Rev-Erba promoter is probably dependent on BMAL1 and CLOCK that bind to E-boxes (Lee et al. 2001) . Interestingly, the peak of PER1 and PER2 binding to the regulatory region of RevErba is 4-6 h after the peak of BMAL1 binding ( Fig. 3A;  Supplemental Fig. 3C ). This may indicate that both PER proteins detach BMAL1 and CLOCK from their regulatory elements and that this contributes to the initiation of repression. A peculiar finding is the binding of REV-ERBa at its own promoter, because it does not interact with PER2, as observed at the Bmal1 promoter. We hypothesize that this difference is rooted in the usage of different DNA regulatory elements for REV-ERBa Lazar 1993, 1995; Preitner et al. 2002; Ueda et al. 2002) .
Bistability of the circadian system in Rev-Erba
Our experiments with double-mutant mice suggest that both REV-ERBa and PER2 participate in the coordination of the oscillator in the SCN. Per2
Brdm1 mice become arrhythmic in constant darkness (Supplemental Fig. 5A ; Zheng et al. 1999) . Interestingly, mice with a loss of RevErba in the Per2
Brdm1 mutant background can display circadian wheel-running behavior (Fig. 5D ). This restoration of rhythmicity may be due to an increase of the Bmal1 mRNA in the SCN (Fig. 5A) , probably leading to higher protein levels. However, the activity of BMAL1 has to be counterbalanced by appropriate amounts of components of the negative limb such as Per1 and Cry1. Previous experiments show that Per1 and Cry1 are sufficient to sustain oscillator function (Oster et al. 2002 (Oster et al. , 2003 . However, expression levels of Per1 and Cry1 in the SCN of Rev-Erba À/À /Per2 mutant mice are lower compared with wild-type and Rev-Erba À/À mice (Fig. 5B,C) , and those levels may not be able to maintain a stable oscillator. Therefore, one can assume that the doublemutant animals may not display rhythmic wheel-running behavior under all conditions. Accordingly, we found that Rev-Erba À/À /Per2 mutant mice can switch from rhythmic to arrhythmic behavior and vice versa ( Fig. 5D; Supplemental Fig. 5D ). We propose that this switch is linked to the levels of negative oscillator components that can fluctuate around a critical threshold. Taken together, constitutive high expression of Bmal1 in the SCN of double-mutant mice is not sufficient to generate a fully functional core loop, as manifested by reduced Per1 and Cry1 levels and the observed behavioral alterations. This is in opposition to the situation found in the liver (Fig. 4) and tissue culture cells (Liu et al. 2008) , where constantly elevated expression of Bmal1 leaves the oscillator functional.
Coupling of metabolic pathways by PER2
The metabolism is made up of anabolic and catabolic pathways. The circadian timing system regulates the temporal separation of these pathways in the liver (Panda et al. 2002; Storch et al. 2002) in order to optimize an organism's performance. Interestingly, nuclear receptors have been implicated in the circadian regulation of metabolically important genes (Yang et al. 2006) . Since many nuclear receptors are not expressed with high circadian amplitude (Supplemental Fig. 4F ; Yang et al. 2006 ), a regulatory mechanism based on nuclear receptors alone may be too imprecise to confer oscillator information to target genes. Our data indicate an additional regulatory mechanism conferring oscillator information based on protein-protein interactions. We observe PER2 impinging on phase and amplitude of rhythmic nuclear receptor target gene expression; for example, Bmal1 and Hnf1a (Figs. 3B-D, 4A; Supplemental Fig. 3A) .
Glucose is produced in hepatic cells by either gluconeogenesis or the catabolism of glycogen. The circadian oscillator also appears to temporally orchestrate these two pathways (Panda et al. 2002; Storch et al. 2002 ) via E-box elements and nuclear receptor elements (NREs) (Fig. 7) . Our results suggest that PER2 can act on both regulatory mechanisms, which allows a precise coupling. In particular, PER2 appears to act on the Pepck1 gene via its interaction with BMAL1 and CLOCK (Fig. 6A ). This notion is based on our observation that expression of Pepck1 mRNA is affected in the various genotypes in a similar manner as the E-box-driven Per1 gene (Figs. 4C,  6A ). In contrast, Hnf1a or G6Pase expression profiles are different and appear to be affected by interaction of PER2 with nuclear receptors (Figs. 3D, 6B; Supplemental Figs. 3A, 6A) such as, for example, HNF4a. Future studies will show how post-translational modifications on PER2 impinge on E-box-and/or NRE-mediated transcription, and how PER2 contributes to the glycogen accumulation phenotype observed in Rev-Erba À/À /Per2 mutant mice. In summary, our findings reveal a novel, fast-responding mechanism of regulation in the circadian oscillator that is based on protein-protein interactions with PER2 as a coregulator of nuclear receptors. In this way, the regulatory potential of PER2 may be extended to link E-boxand NRE-regulated pathways (Fig. 7) . If coupling of such pathways is interrupted, coordination of metabolism may be affected and fitness of the organism may be reduced. This might point toward novel strategies to suppress malignant growth and treatment of diseases rooted in the circadian system.
Materials and methods
Plasmids
Full-length mouse cDNAs encoding PER2, PER1, CRY1, REVERBa, RORa, ERa, NURR1, PPARa, HNF4a, RXRa, and THRa were fused in-frame to either two N-terminal HA tags or two C-terminal V5 tags. For accession numbers, vectors, mutations, and oligonucleotides, see Supplemental Tables 1 and 2 . To obtain Rev-Erba luciferase, a 6.6-kb fragment of the mRev-Erba gene, starting at the unique MluI restriction enzyme site (;3.5 kb upstream of the transcriptional start site) to the beginning of exon 2, was modified at the 39 site and cloned into the pGL3 basic vector (Promega). This constructs expresses, after appropriate splicing, an in-frame fusion protein containing the first 16 amino acids of mREV-ERBa and the firefly luciferase. The Bmal1 luc construct was from . The longer Bmal1 luciferase construct (Bmal1 ext. luc) refers to a 59 extension of Bmal1 luc by 822 additional base pairs to include the PPARaregulatory site (Canaple et al. 2006 ).
Real-time bioluminescence monitoring
Proliferating NIH 3T3 cells cultured in DMEM High Glucose (Sigma-Aldrich) supplemented with 10% fetal calf serum and 100 U/mL penicillin/streptomycin (Amimed) were transfected with 0.1 mg of pSEAP, 1.8 mg of the luciferase reporter constructs, and the indicated amounts of expression vectors using JetPEI (Polyplus Transfection) in 35-mm culture dishes. Cells were synchronized 48 h after transfection by addition of DMEM containing 100 nM dexamethasone (Balsalobre et al. 2000) . After 20 min, the medium was changed to phenol red-free DMEM supplemented with 0.1 mM luciferin and 5% fetal calf serum. Bioluminescence was monitored continuously and was analyzed using LumiCycle analysis software (Actimetrics). Raw data were normalized to SEAP activity (Roche Applied Science) in a culture medium sample taken before synchronization as transfection control.
Coimmunoprecipitation analysis using V5-and HA-tagged proteins NIH 3T3 cells were transfected in 10-cm dishes using linear polyethylenimine (LINPEI25; Polysciences Europe). The amounts of expression vectors were adjusted to yield comparable levels of expressed protein. Forty-eight hours after transfection, cells were harvested and nuclear extracts were prepared (see the Figure 7 . Model of how PER2 may couple E-box-driven and nuclear receptor-regulated gene expression. In the oscillator, both PER proteins act as repressors of E-box-mediated circadian transcription via interaction with BMAL1 and CLOCK. In addition, PER2 can modulate NRE-mediated transcription via interaction with nuclear receptors. This affects expression of Bmal1 in the oscillator and target genes in the output such as Hnf1a may be regulated. These output targets can be modulated via E-boxes, NREs, or both. PER2-nuclear receptor interactions may be involved in this regulatory process (hatched arrows) to coordinate clock output processes.
Supplemental Material) and adjusted to a final salt concentration of 150 mM NaCl. Twenty micrograms of nuclear protein extract in 250 mL of lysis puffer with 150 mM NaCl and 0.1% Triton X-100 were incubated with 15 mL of aHA agarose (SigmaAldrich) overnight at 4°C. Beads were collected by centrifugation and washed four times with lysis buffer supplemented with 1% Triton X-100 and 150 mM NaCl. Samples were boiled and subjected to SDS-PAGE.
Protein extraction and Western blot analysis
Mouse liver nuclei were purified according to Ripperger et al. (2000) . Nuclear extracts were prepared according to the NUN procedure (Lavery and Schibler 1993) . SDS-PAGE and Western blot analysis were performed according to standard protocols. Antibodies used were rabbit PER1, PER2, CRY1, BMAL1, CLOCK, REV-ERBa (Preitner et al. 2002) ; PPARa (Cayman); RORa (Abcam), RNA POLII (Bethyl); HNF4a (a gift from U. Schibler); rat HA (Roche Applied Science); and mouse V5 (Sigma-Aldrich).
Coimmunoprecipitation analysis using liver nuclear extracts
For coimmunoprecipitation experiments with mouse liver nuclear extracts, 200 mg of nuclear extract were incubated in rotation overnight at 4°C with the indicated antibody and captured with protein A agarose beads (Roche Applied Science) for 2 h at 4°C. The beads were washed according to Asher et al. (2008) . After four washes, beads were resuspended in 2% SDS/10% glycerol in 63 mM Tris-HCl (pH 6.8), and proteins were eluted for 15 min at room temperature. DTT was added to a concentration of 10 mM to the eluate, and the samples were boiled and subjected to SDS-PAGE.
ChIP
Liver tissue (;1 g) was homogenized in 13 PBS with 1% formaldehyde. The cross-linking was continued for 5 min at room temperature. The procedure of chromatin preparation, immunoprecipitation of cross-linked DNA fragments, the washing conditions, the reversal of the cross-links, the antibodies used, and the quantification of the DNA fragments by real-time PCR were described already in Ripperger and Schibler (2006) . The real-time PCR probes are listed in Supplemental Table 3 .
RNA extraction, reverse transcription, and real-time PCR detection
Total RNA was extracted from cells and liver tissue using RNABee (AMS Biotechnology) according to the manufacturer's instructions. Liver RNA was precipitated in 4 M LiCl to remove glycogen, and was purified further by phenol:chloroform extraction and ethanol precipitation. ssDNA complementary to the RNA starting from hybridized random hexamer primers was synthesized with SuperScript II (Life Technology Corporation) according to the manufacturer's instructions. Real-time PCR probes have been described (Supplemental Table 3 ; Preitner et al. 2002) . All RNA samples were normalized to Gapdh mRNA accumulation. Relative mRNA levels were assessed by defining the highest value of each experiment in wild-type animals as 100%.
Animals
Animal care and handling was performed according to the Canton of Fribourg's law for animal protection authorized by the Office Veterinaire Cantonal de Fribourg. We crossed Per2 Brdm1 mice (Zheng et al. 1999 ) with Rev-Erba knockout animals (Preitner et al. 2002) . The genotype of the offspring was determined by PCR (see Supplemental Table 3 ).
Locomotor activity monitoring
Mice housing and handling was performed as described (Jud et al. 2005) . Activity records are double-plotted so that each day cycle's activity is plotted both to the right and below that of the previous cycle. We used the Clocklab software (Actimetrics) for wheel-running data acquisition and analysis. The freerunning period length during the first 5-7 d in constant darkness was calculated by x 2 periodogram analysis.
In situ hybridization
Specimen preparation, 35 S-UTP-labeled riboprobe synthesis, and hybridization steps were performed as described . The in situ hybridization probes for Per1 ) and for Bmal1 and Cry1 (Oster et al. 2002) are described. Quantification was performed according to Oster et al. (2002) using the Quantity One 1-D analysis software (Bio-Rad). We assessed the ''relative mRNA abundance'' values by defining the highest value of each experiment in wild-type animals as 100%.
Liver glycogen determination
Liver pieces were weighted and adjusted with 2 M hydrochloric acid to a final concentration of 0.1 mg/mL (Lamia et al. 2008) . After sonication, samples were boiled for 3 h with constant agitation to convert glycogen in glucose and glucose 6-phosphate. The solution was neutralized with an equal volume of 2 M NaOH and 8 vol of 100 mM Tris (pH 7.4). Glucose was determined using the glucose-hexokinase kit (Sigma-Aldrich).
PAS staining
Small pieces of the liver were dissected and fixed in 4% paraformaldehyde in 13 PBS. Specimens were dehydrated, embedded in paraffin, and sectioned to 4-mm thickness. Sections were stained with periodic acid-Schiff's method to demonstrate carbohydrates, and were counterstained with Mayer's hematoxylin solution (Sigma-Aldrich) according to the manufacturer's instructions.
Measurement of enzymatic activities
Liver homogenates were prepared in ice-cold 100 mM Tris (pH 7.5), 0.25 M sucrose, 5 mM EDTA, and 1 mM PMSF and centrifuged at 10,500g for 20 min. The supernatant was centrifuged further at 100,000g for 1 h. The resulting supernatant (cytosol) was collected and stored at À70°C until PEPCK assay. The resulting pellet (microsomes) was resuspended in 100 mM Na-cacodylate (pH 6.5)/10% glycerol and stored at À70°C until G6Pase assay. Total protein of the two fractions was determined using a BCA protein assay kit (Sigma-Aldrich). PEPCK activity was measured at 30°C as described by Petrescu et al. (1979) . Briefly, phosphoenolpyruvate was carboxylated by PEPCK to form oxalacetate, which was converted further to malate using malic dehydrogenase. This conversion was monitored as decrease of NADH. Activity was expressed as milliunits per milligram of protein in liver supernatant (1 mU = 1 nmol of oxalacetate produced per minute). G6Pase activity was assayed according to Nordlie and Arion (1966) . Activity was expressed as milliunits per milligram of protein in the microsomes (1 mU = 1 nmol of anorganic phosphate released per minute).
Statistical analysis
Statistical analysis of all experiments was performed using Prism4 software (GraphPad Software, Inc.). Significant differences between groups were determined using one-or two-way ANOVA, followed by Bonferroni's post-test. Values were considered significantly different with P < 0.05 (*), P < 0.01 (**), or P < 0.001 (***). 
Supplemental data
Supplemental materials and methods
Nuclear extracts from NIH 3T3 mouse fibroblasts
Nuclear extracts were prepared by swelling the cells in 100 mM Tris-HCl pH 8.8/ 10 mM DTT and subsequent hypotonic lysis (10 mM EDTA, 1 mM EGTA, 10 mM Hepes pH 6.8, 0.2% Triton-X 100, 0.5 mM DTT, protease inhibitor cocktail). After centrifugation for 5 minutes at 2,500 g and 4°C, the supernatant was stored as cytosolic fraction. The pellet was washed once with the same buffer and resuspended in 1 mM EDTA/1 mM EGTA/10 mM Hepes, pH 6.8/10% glycerol/300 mM NaCl/ 0.5 mM DTT and protease inhibitor cocktail (Roche Applied Science). Samples were incubated for 20 minutes on ice and centrifuged for 20 minutes at 16,000 g and 4°C.
The supernatant was stored as the nuclear fraction at -70°C.
Co-immunoprecipitation analysis
For co-immunoprecipitation with HA-REV-ERBα, 20 µg of nuclear protein extract were incubated in the presence of 0.1% Triton-X 100 with 3 µl αHA antibody (Roche) or 15 µl αHA agarose (Sigma-Aldrich) in rotation over night at 4°C. αHA antibody was captured with protein A agarose beads for two hours at 4°C. Beads were collected by centrifugation and washed four times using lysis buffer supplemented with 1% Triton-X 100 and 150 mM NaCl. Laemmli sample buffer was added, samples were boiled and subsequently subjected to SDS-PAGE (Laemmli 1970) .
Quantification of the Area under the curve
Bioluminescence counts over several days were quantified by measuring the area under the curve (AUC) as a measure of the total reporter activity using Prism4 software (GraphPad software Inc., La Jolla, CA). To compare the effects of the overexpressed proteins on luciferase reporter expression, the AUC of the luciferase reporter vector alone was defined as 100 % and the AUC values of the cotransfections were calculated relative to 100 %.
Succinylacetone and hemin treatment
Cells were switched 24 hrs after transfection to serum free medium supplemented with or without succinylacetone (5 mM; Sigma-Aldrich) overnight. For the hemin (Sigma-Aldrich) treatment, cells were treated with either solvent or hemin (6 µM) for 6 hrs. Nuclear extracts were prepared as described above. An aliquot of cells from the treated cultures was taken for RNA extraction.
Blood glucose determination
Blood samples were collected in clotting activator coated capillaries (Microvette 100, Sarstedt) and serum was recovered after centrifugation for 10 min at 3,300 g. Glucose
was measured with the glucose-hexokinase reagent (Sigma-Aldrich) and normalized to a control serum used in each experiment.
Supplemental figure legends
Supplemental figure Note that PER1 and PER2 both diminish the expression of Rev-Erbα luc in a dose dependent manner, whereas they act differently on Bmal1 luc expression. After reaching a peak of bioluminescence activity, even higher amounts of PER2 expression vector abolished this activation. ** P < 0.01, *** P < 0.001 indicating significance (One-way ANOVA). Error bars represent standard deviation (data combined from 8 independent experiments). (Hampp et al., 2008) --Bmal1 luciferase --Rev-Erbα luciferase --To obtain Rev-Erbα-luciferase, a 6.6 kbp fragment of the mRev-Erbα gene, starting at the unique MluI restriction enzyme site (about 3.5 kbp upstream from the transcriptional start site) to the beginning of exon 2, was modified at the 3' site and cloned into the pGL3 basic vector (Promega, Madison, USA). This constructs expresses after appropriate splicing an in frame fusion protein containing the first 16 amino acids of mREV-ERBα and the firefly luciferase.
Bmal1 ext luciferase
5' extension of Bmal1 luciferase by 822 bp to include the PPARα-regulatory site (Canaple et al., 2006) . Table S1 . Vectors used in this study. Corresponding accession numbers and the nuclear receptor nomenclature are indicated. pSCT1 HAPparα (K292A) Pparα(KtoA292)-FW 5`-GAG CTC ACA GAA TTT GCC GCG GCT ATC CCA GGC TTT GC-3` mutation of aa K292 to alanine f aa L459-Y468 site-directed mutagenesis Pparα(KtoA292)-RV 5`-GCA AAG CCT GGG ATA GCC GCG GCA AAT TCT GTG AGC TC-3` pSCT1 HAPparα ΔH12 Pparα(ΔH12)-S 5`-GCT GCA CCC ATA ACA CGT-3` deletion of aa L459-Y468 deletion Pparα(ΔH12)-AS 5`-ACG TGT TAT GGG TGC AGC-3` Table S2 . Strategies to change specific regions or amino acids of the indicated expression vectors.
